http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2358929-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4afb8b01aa8de7e0b24a86713b23a18 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2866 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate | 2007-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d0a2e8cf0f0ed0a65a639084b840643 |
| publicationDate | 2011-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2358929-T3 |
| titleOfInvention | METHOD FOR TREATING DEMIELINIZING DISEASES. |
| abstract | The use of an antibody against IL-18Rα in which the antibody has an antigen binding domain comprising six CDRs with an amino acid sequence consisting of: SEQ ID NO: 5 representing the heavy chain of CDR1, SEQ ID NO : 6 representing the heavy chain of CDR2, SEQ ID NO: 7 representing the heavy chain of CDR3, SEQ ID NO: 8 representing the light chain of CDR1, SEQ ID NO: 9 representing the light chain of CDR2 and SEQ ID NO: 10 representing the light chain of CDR3 in the manufacture of a medicament for the treatment of a demyelinating disease. |
| priorityDate | 2006-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 397.